Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES. [electronic resource]
Producer: 20190319Description: 169-178 p. digitalISSN:- 1573-7217
- Aged
- Androstadienes -- pharmacology
- Antineoplastic Agents, Hormonal -- pharmacology
- Breast -- pathology
- Breast Neoplasms -- mortality
- Chemotherapy, Adjuvant -- methods
- Disease-Free Survival
- Double-Blind Method
- Drug Resistance, Neoplasm
- Female
- Humans
- Immunohistochemistry
- Mastectomy
- Middle Aged
- Neoplasm Recurrence, Local -- epidemiology
- Prognosis
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Tamoxifen -- pharmacology
- Time Factors
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.